这是一篇来自已证抗体库的有关
小鼠 纤维生长因子2 (Fgf2) 的综述,是根据8篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合纤维生长因子2 抗体。
纤维生长因子2 同义词: Fgf-2; Fgfb; bFGF
圣克鲁斯生物技术
小鼠 单克隆(G-2) | | 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz, sc-365106)被用于被用于免疫印迹在小鼠样本上 (图 6a). Int J Mol Sci (2021) ncbi |
小鼠 单克隆(G-2) | | 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz Biotechnology, SC-365106)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 1d). Brain Pathol (2021) ncbi |
小鼠 单克隆(A-1) | - 免疫印迹; 小鼠; 1:1000; 图 2e, 2f
| 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz, sc-271847)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2e, 2f). Sci Rep (2020) ncbi |
小鼠 单克隆(C-2) | | 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz, sc-74412)被用于被用于免疫印迹在人类样本上 (图 2). Stem Cells Dev (2016) ncbi |
小鼠 单克隆(G-2) | | 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz, sc-365106)被用于被用于免疫组化-冰冻切片在大鼠样本上 (图 2). Sci Rep (2016) ncbi |
小鼠 单克隆(A-1) | | 圣克鲁斯生物技术纤维生长因子2抗体(Santa Cruz, sc-271847)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5). Stem Cells Int (2016) ncbi |
小鼠 单克隆(G-2) | - 免疫组化-冰冻切片; 大鼠; 1:300; 图 4
| 圣克鲁斯生物技术纤维生长因子2抗体(santa Cruz, sc-365106)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:300 (图 4). Hypertension (2015) ncbi |
MyBioSource
domestic rabbit 多克隆 | | MyBioSource纤维生长因子2抗体(MyBioSource, MBS551041)被用于被用于免疫印迹在大鼠样本上 (图 5c). Stem Cell Res Ther (2021) ncbi |
Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C,
et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22:
pubmed 出版商
Ji Z, Chen S, Cui J, Huang W, Zhang R, Wei J,
et al. Oct4-dependent FoxC1 activation improves the survival and neovascularization of mesenchymal stem cells under myocardial ischemia. Stem Cell Res Ther. 2021;12:483
pubmed 出版商
Kamali S, Rajendran R, Stadelmann C, Karnati S, Rajendran V, Giraldo Velasquez M,
et al. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling. Brain Pathol. 2021;31:297-311
pubmed 出版商
Ichikawa K, Watanabe Miyano S, Minoshima Y, Matsui J, Funahashi Y. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Sci Rep. 2020;10:2939
pubmed 出版商
Jung J, Kang K, Kim J, Hong S, Park Y, Kim B. CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, ?-Catenin, and hTERT Activities. Stem Cells Dev. 2016;25:1006-19
pubmed 出版商
Holditch S, Schreiber C, Burnett J, Ikeda Y. Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females. Sci Rep. 2016;6:25623
pubmed 出版商
Lu W, Su L, Yu Z, Zhang S, Miao J. The New Role of CD163 in the Differentiation of Bone Marrow Stromal Cells into Vascular Endothelial-Like Cells. Stem Cells Int. 2016;2016:2539781
pubmed 出版商
Holditch S, Schreiber C, Nini R, Tonne J, Peng K, Geurts A,
et al. B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension. Hypertension. 2015;66:199-210
pubmed 出版商